Venues for marijuana users will be the next big thing for American states who want to legalize the use of medical weed. Although there areas across the United States that allow the use of the cannabis plant, none allows it to be smoked or used in public.
Washington, Colorado, Oregon and the District of Columbia have laws that allow users to possess a specified amount of grass. In addition, the places where they are allowed to use it is within the confines of their homes or in houses where they are guests.
Early voter initiatives have ruled out the utilization of public areas to accommodate cannabis users. This is actually a major hindrance for visitors or tourists who have nowhere to put their weed habit in place. Considering that most hotels have instituted a ban on cannabis consumption, the idea of instituting halls or shops for marijuana users is a welcome development.
In November last year, the Alaska Marijuana Control Board has issued draft regulations to define when and where on-site consumption will be permitted. Voting for its approval is yet to happen.
When Colorado legalized marijuana in 2012, its intention is for private consumption only. This fall, the state will have a chance to legalize the weed's public use through the polls.
The key, however, to this initiative is the issuance of permit from the local neighborhood association, business improvement district or merchant group prior to the approval of Denver's licensing officials.
Considering the legality of the grass, it is possible that the government will institute regulations. A huge part of this approach involves the revenues to be earned on matters related to the weed.
There will be safety precautions in terms of manufacturing. Certification for laboratories will also be needed. Of course, tax revenues will not be far behind.
Considering the parameters of legal consumption, regulating the act is much better than having people use marijuana clandestinely. In the course of marijuana distribution, the production of synthetic forms is highly likely for a growing market.
For instance, the approval of Syndros by the Food and Drug Administration (FDA) is part of the regulatory campaign of the agency. This liquid version of the synthetic cannabinoid pill Marinol can be used to treat ailments in AIDS and cancer patients.
